Nu-Med Plus (Nu-Med Plus) Forward Dividend Yield % : 0.00% (As of Jun. 02, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nu-Med Plus Forward Dividend Yield %?

As of today (2024-06-02), the Forward Annual Dividend Yield of Nu-Med Plus is 0.00%.

As of today (2024-06-02), the Trailing Annual Dividend Yield of Nu-Med Plus is 0.00%.

NUMD's Forward Dividend Yield % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.94
* Ranked among companies with meaningful Forward Dividend Yield % only.

Nu-Med Plus's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Nu-Med Plus's Forward Dividend Yield %

For the Medical Devices subindustry, Nu-Med Plus's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nu-Med Plus's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nu-Med Plus's Forward Dividend Yield % falls into.

Nu-Med Plus Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Nu-Med Plus (OTCPK:NUMD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Nu-Med Plus Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Nu-Med Plus's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nu-Med Plus (Nu-Med Plus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nu-Med Plus Inc (OTCPK:NUMD) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

640 Belle Terre Road, Building 2 E Port, Jefferson, NY, USA, 11777

Website

https://www.nu-medplus.com

Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.

Executives

William C Hayde	director, officer: CEO	76 CLIFF ROAD, BELLE TERRE NY 11777
Wendy P. Smith	10 percent owner	P. O. BOX 1374, SALT LAKE CITY UT 84110
Brett J. Earl	director, officer: VP of Medical Marketing	P.O. BOX 729, MORGAN UT 84050
Mark Edward Christensen	officer: CFO, Sec, Treas, Prin Acct Off	455 E. 500 S., SUITE 207, SALT LAKE CITY UT 84111
Thomas A Tait	10 percent owner	514 AMERICAS WAY #5556, BOX ELDER SD 57719
Craig Morrison	director, 10 percent owner, officer: Vice President of Technology	975 NORTH TERRACE DRIVE, PROVO UT 84604
William G Moon	director, 10 percent owner, officer: Vice President of Operations	1266 SOUTH 1380 WEST, OREM UT 84058
Jeffrey Lynn Robins	director, 10 percent owner, officer: CEO	455 EAST 500 SOUTH, SUITE #205, SALT LAKE CITY UT 84111